Seller record · pauserx.com

PauseRX

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S5, analytical documentation: No certificate or lot document is published on the product pages, in the answers or in the terms, privacy and returns policies. 1 more criterion also fails; see the table below.

At a glance

PauseRXpauserx.com

6/8criteria passed

Price: Semaglutide $199, tirzepatide from $249 a month
Sells: compounded semaglutide, compounded tirzepatide, and 8 more
FDA letters: None on file

Visit PauseRX See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling semaglutide and tirzepatide plans at flat monthly prices, beside sermorelin, NAD+, glutathione, PT-141 and GHK-Cu, and consultation plans for Wegovy and Zepbound. It names Rush Pharmacy as its pharmacy and prints two different addresses for itself.

Operating entity PauseRX, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	pauserx.com/personalized-glp-1, pauserx.com
S2	Prescription gating	PASS	intake.pauserx.com/visit/weightloss, pauserx.com/glp-branded-medication
S3	Pharmacy identification	PASS	pauserx.com/faq, pauserx.com/returns-refund-policy
S4	Compounding disclosure	PASS	pauserx.com/microdose, pauserx.com/personalized-glp-1
S5	Analytical documentation	FAIL	pauserx.com/faq, pauserx.com/all-treatment
S6	Business address	FAIL	pauserx.com/privacy-policy, pauserx.com/hipaa-notice, pauserx.com/returns-refund-policy
S7	Price disclosure	PASS	pauserx.com, pauserx.com/personalized-glp-1-gip, pauserx.com/sermorelin, pauserx.com/glp-branded-medication
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSLicensed U.S. physicians review a health questionnaire and write the prescription, and medication ships only if prescribed after that review.Source: pauserx.com/personalized-glp-1, pauserx.com.

S2PASSEvery start button opens a health assessment that begins with an account screen and telehealth consent, and no cart exists. Brand-name plans charge for medication only upon consult approval.Source: intake.pauserx.com/visit/weightloss, pauserx.com/glp-branded-medication.

S3PASSRush Pharmacy is named as the pharmacy in the answers, and the privacy and returns policies print it at 1977 Alafaya Trail #1121, Oviedo, FL 32765.Source: pauserx.com/faq, pauserx.com/returns-refund-policy.

S4PASSCompounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality, printed in the footer of every page and beneath the microdose plans. The semaglutide and tirzepatide pages never call the drug compounded, and their image caption describes FDA-approved branded products.Source: pauserx.com/microdose, pauserx.com/personalized-glp-1.

S5FAILNo certificate or lot document is published on the product pages, in the answers or in the terms, privacy and returns policies.Source: pauserx.com/faq, pauserx.com/all-treatment.

S6FAILPauseRX prints two different addresses for itself. The privacy contact section and the HIPAA notice give 2006 N Sepulveda Blvd #1102, Manhattan Beach, CA 90266, while the privacy retention section and the returns policy give Pause Rx and Rush Pharmacy at 1977 Alafaya Trail #1121, Oviedo, FL 32765.Source: pauserx.com/privacy-policy, pauserx.com/hipaa-notice, pauserx.com/returns-refund-policy.

S7PASSThe semaglutide plan is printed at $199 a month at every dose and the tirzepatide plan from $249 a month, with sermorelin injection from $349, NAD+ and glutathione injections from $249, PT-141 from $299 and GHK-Cu cream from $199. The Wegovy and Zepbound plans are $149 a month for the consultation, with medication charged separately.Source: pauserx.com, pauserx.com/personalized-glp-1-gip, pauserx.com/sermorelin, pauserx.com/glp-branded-medication.

S8PASSNo FDA warning letter names PauseRX, Pause Rx or the operating entity PauseRX, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin injection and troches, NAD+ injection and troches, glutathione injection and nasal spray, PT-141, GHK-Cu cream, Wegovy, Zepbound, hormone therapy and testosterone.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione Who sells PT-141 Who sells GHK-Cu

Unpaid link. PauseRX does not pay the site, and nothing is earned when it is used. Funding.

Visit PauseRX

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.